Cencora demonstrated a strong start to fiscal 2025, with double-digit revenue and EPS growth driven by its U.S. healthcare solutions segment and strategic expansion in specialty services through ...

Stock analysts at Leerink Partnrs raised their FY2028 EPS estimates for shares of Cencora in a note issued to investors on ...

Cencora COR +0.57% Get Free Report has outperformed the market over the past 10 years by 7.55% on an annualized basis ...

Cencora has made headlines with its announcement on March 10, 2025, detailing plans for strategic acquisitions and investments in technology infrastructure, aiming to drive future growth.

Cencora, Inc. COR is well-poised for growth on the back of robust U.S ... This acquisition complements COR’s pharmaceutical-centric strategy, strengthens its Management Services Organization ...